Sushma. NC, J Adlin Jino Nesalin, E. Gopinath, Vineeth Chandy
Sushma. NC*, J Adlin Jino Nesalin, E. Gopinath, Vineeth Chandy
Department of Pharmaceutics, T. John College of Pharmacy, Bangalore, Karnataka, India.
Volume - 13,
Issue - 3,
Year - 2023
The nanotechnology sector is regarded as a developing technology due to its capacity to improve the already existing items and create new ones for a range of uses. The primary drivers of this expansion are cyclodextrin-based porous nanoparticles or distinctive nanosponges, which have lately been applied in the pharmaceutical, biomedical, and cosmetic industries. This superior technology can circumvent the defects of current techniques through its ability to attack and visualize tumor sites. The organization of this review article is such that we first looked at the distinctive characteristics of these nanosponges and the various synthesizing techniques, then about the drug loading and release principle and applications based on drug delivery, targeting, increasing the solubility of BCS Class II and IV drugs, other applications in biomedicine, and more. The most recent developments on the employment of biomimetic nanosponge as a pandemic tool because of the SARS-CoV-2 virus briefly align. Due to several significant limitations, effective targeted drug delivery systems have long been an aspiration. These issues might be resolved by the creation of new colloidal carriers termed Nanosponges.
Cite this article:
Sushma. NC, J Adlin Jino Nesalin, E. Gopinath, Vineeth Chandy. An Outlook towards Nanosponges: A Propitious Nanocarrier for Novel Drug Delivery. Asian Journal of Research in Pharmaceutical Sciences. 2023; 13(3):248-4. doi: 10.52711/2231-5659.2023.00043
Sushma. NC, J Adlin Jino Nesalin, E. Gopinath, Vineeth Chandy. An Outlook towards Nanosponges: A Propitious Nanocarrier for Novel Drug Delivery. Asian Journal of Research in Pharmaceutical Sciences. 2023; 13(3):248-4. doi: 10.52711/2231-5659.2023.00043 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2023-13-3-11
1. Rao MRP, Chaudhari J, Trotta F, Caldera F. Investigation of cyclodextrin-based nanosponges for solubility and bioavailability enhancement of Rilpivirine. AAPS Pharm Sci Tech. 2018; 19(5):2358-69.
2. Vishwakarma A, Nikama P, Mogal R, Talele S. Review on nanosponges: A Benefication for Novel Drug Delivery. Vishwakarma A, Nikam P, Mogal R, Talele S. Review On Nanosponges: A Beneficiation For Novel Drug Delivery. Int J pharmtech Res. 2014; 6(1):11-20.
3. Panda S, Pattnaik S, Swain RP, Vijayalakshmi SV. Nanosponges: A novel carrier for targeted drug delivery. Int J Pharmtech Res.2015; 8(7):213-224.
4. Iravani S, Varma RS. Nanosponges for Drug Delivery and Cancer Therapy: Recent Advances. Nanomaterials.2022; 12(14):24-40.
5. Shringirishi M, Prajapati S.K, Mohar A, Alok S, Yadav P, Verma A. Nanosponges: A potential nanocarrier for novel drug delivery – a review. Asian Pac J Trop Dis. 2014; 4(2):519-526.
6. Prabhu PP, Prathvi, Gujaran TV, Mehta CH, Suresh A, Koteshwara KB, Development of Lapatinib nanosponges for enhancing bioavailability. J Drug Deliv Sci Technol. 2021; 65(10):1-11.
7. Bhowmik H, Venkatesh DN , Kuila A, Kumar KH. Nanosponges: A review. Int. J. Pharm 2018; 10(4):975-7058.
8. Ghurghure SM, Pathan MSA, Surwase PM. Nanosponges: A novel approach for targeted drug delivery system. Int. J. Chem. Stud.2018; 2(6):15-23.
9. Jilsha G, Viswanad V. Nanosponges: A Novel Approach of Drug Delivery System. Int. J. Pharm. Sci. Rev.2013; 19(2):119-123.
10. Rao MR, Sonawane A, Sapate S, Paul G, Rahom S. Nanosponges: A Multifunctional Drug Delivery System. IJARESM Publication.2021; 9(5):1-13.
11. Tiwari K, Bhattacharya S. The ascension of nanosponges as a drug delivery carrier: preparation, characterization, and applications. J Mater Sci Mater Med.2022; 33(3):28.
12. Sharma R, Walker RB, Pathak K. Evaluation of the Kinetics and Mechanism of Drug Release from Econazole nitrate Nanosponge Loaded Carbapol Hydrogel. Ind J Pharm Edu Res.2011; 45(1):1-7.
13. Kaur S, Kumarn S. Nanosponges: An Innovative Drug Delivery System. Asian J Pharm Clin Res. 2019; 12(7):60-67.
14. Atchaya J, Girigoswami A, Girigoswami K. Versatile Applications of Nanosponges in Biomedical Field: A Glimpse on SARS CoV 2 Management. BioNanoScience. 2022; 12(3):1018-31.
15. Simranjot K, Sandeep K. Nanosponges: Present aspects and future challenges. IAJPS 2018; 5(9):9390-98.
16. Khan KAA, Bhargav E, Reddy KR, Sowmya C. Nanosponges: A New Approach for Drug Targeting. IJPPR.2016; 7(3):381-396.
17. Bano N, Ray SK, Shukla T, Upmanyu N, Khare R, pandey SP. Multifunctional nanosponges for the treatment of various diseases: A review. Asian J Pharm Pharmacol. 2019; 5(2):235-248.
18. Ansari KA, Pradeep R. Vavia, Trotta F, Cavalli R. Cyclodextrin-based nanosponges for delivery of Resveratrol: In Vivo characterization, stability, cytotoxicity, and permeation study. AAPS PharmSciTech.2011; 12(1):279-286.
19. Almutairt BK, Alshetaili A, Alali AS, Ahmed MM, Anwer MK, Aboudzadeh MA. Design of Olmesartan Medoxomil-loaded nanosponges for hypertension and lung cancer treatment. Polymers 2021; 13(7):1-8.
20. Swaminathan S, Pastero L, Serpe L, Trotta F, Vavia P, Aquilano D, GianPaolo Zara. Cyclodextrin-based nanosponges encapsulating Camptothecin: Physicochemical characterization, stability, and cytotoxicity. Eur J Pharm Biopharm. 2010; 74(2):193–201.
21. Singh R, Bharti N, Madan J, Hiremath SN. Characterization of cyclodextrin inclusion complexes – A Review. J. Pharm. Sci. Technol. 2010; 2(3):171-183.
22. Ahmed RZ, Patil G, Zaheer Z. Nanosponges – a completely new nano-horizon: pharmaceutical applications and recent advances. Drug Dev Ind Pharm. 2013; 39(9):1263-1272.
23. Nolan LM, Li J, Tajber L, Corrigan OI, Healy AM. Particle engineering of materials for oral inhalation by dry powder inhalers. II—Sodium cromoglicate. Int J Pharm.2011; 405(1-2):36-46.
24. Subramanian S, Singireddy A, Krishnamoorthy K, Rajappan M. Nanosponges: A Novel Class of Drug Delivery System – Review. J Pharm Pharmaceut Sci .2012; 15(1):103 – 111.
25. Chhabria V, Beeton S. Development of nanosponges from erythrocyte ghosts for removal of streptolysin-O from mammalian blood. Nanomedicine .2016; 11(21):2797–2807.
26. Che-Ming J . Hu, Ronnie H. Fang, Copp J, Luk BT, Zhang L. A Biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol. 2013; 8(5):336-340.
27. S. Sapino, M. E. Carlotti , R. Cavalli ,E. Ugazio, G. Berlier, L. Gastaldi , S. More. Photochemical and antioxidant properties of gamma-oryzanol in beta-cyclodextrin-based nanosponges. J Incl Phenom Macrocycl Chem.2012; 1(3):1-8.
28. Rao L, Xia S, Xu W, Tian R, Yu G, Gu C. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc Natl Acad Sci U S A. 2020; 117(44):27141-147.
29. Zhang Q, Honko A, Zhou J, Gong H, Downs SN, Vasquez JH. Cellular Nanosponges Inhibit SARS-CoV 2 Infectivity. Nano Lett. 2020; 20(7):5570−74.
30. Shivani S, Poladi KK. Nanospones- novel emerging drug delivery system: a review. Int J Pharm Sci Res. 2015; 6(2):529-540.
31. Tejashri G, Amrita B, Darshana J. cyclodextrin based nanosponges for pharmaceutical use: A review. Acta Pharm. 2013; 63(3):335-358
32. Salazar S, Yutronic N, Jara P. Magnetic β-Cyclodextrin Nanosponges for Potential Application in the Removal of the Neonicotinoid Dinotefuran from Wastewater. Int. J. Mol. Sci.2020; 21(11):1-24.